These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19329989)

  • 21. Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V.
    Lee HJ; Park J; Nakhro K; Park JM; Hur YM; Choi BO; Chung KW
    J Peripher Nerv Syst; 2012 Dec; 17(4):418-21. PubMed ID: 23279345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation in the GARS gene in a Malian family with Charcot-Marie-Tooth disease.
    Yalcouyé A; Diallo SH; Coulibaly T; Cissé L; Diallo S; Samassékou O; Diarra S; Coulibaly D; Keita M; Guinto CO; Fischbeck K; Landouré G;
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00782. PubMed ID: 31173493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype.
    Abe A; Numakura C; Saito K; Koide H; Oka N; Honma A; Kishikawa Y; Hayasaka K
    J Hum Genet; 2009 Feb; 54(2):94-7. PubMed ID: 19158810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of hereditary neuropathies.
    Chance PF
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular analysis of the genes causing recessive demyelinating Charcot-Marie-Tooth disease in Japan.
    Hayashi M; Abe A; Murakami T; Yamao S; Arai H; Hattori H; Iai M; Watanabe K; Oka N; Chida K; Kishikawa Y; Hayasaka K
    J Hum Genet; 2013 May; 58(5):273-8. PubMed ID: 23466821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21.
    Ismailov SM; Fedotov VP; Dadali EL; Polyakov AV; Van Broeckhoven C; Ivanov VI; De Jonghe P; Timmerman V; Evgrafov OV
    Eur J Hum Genet; 2001 Aug; 9(8):646-50. PubMed ID: 11528513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.
    Malissovas N; Griffin LB; Antonellis A; Beis D
    Hum Mol Genet; 2016 Apr; 25(8):1528-42. PubMed ID: 27008886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene.
    Birouk N; Azzedine H; Dubourg O; Muriel MP; Benomar A; Hamadouche T; Maisonobe T; Ouazzani R; Brice A; Yahyaoui M; Chkili T; Le Guern E
    Arch Neurol; 2003 Apr; 60(4):598-604. PubMed ID: 12707075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease.
    Nan H; Takaki R; Hata T; Ichinose Y; Tsuchiya M; Koh K; Takiyama Y
    J Peripher Nerv Syst; 2019 Mar; 24(1):156-160. PubMed ID: 30394614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited neuropathies: Charcot-Marie-Tooth disease and related disorders.
    Chance PF; Lupski JR
    Baillieres Clin Neurol; 1994 Aug; 3(2):373-85. PubMed ID: 7952853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
    Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
    Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement].
    Kawakami N; Komatsu K; Yamashita H; Uemura K; Oka N; Takashima H; Takahashi R
    Rinsho Shinkeigaku; 2014; 54(11):911-5. PubMed ID: 25420567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From gene to disease; Charcot-Marie-Tooth disease or the hereditary motor and sensory neuropathies].
    Verhamme C; Baas F
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1505-9. PubMed ID: 16032995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
    Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
    J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT2-knockdown rescues GARS-induced Charcot-Marie-Tooth neuropathy.
    Zhao Y; Xie L; Shen C; Qi Q; Qin Y; Xing J; Zhou D; Qi Y; Yan Z; Lin X; Dai R; Lin J; Yu W
    Aging Cell; 2021 Jun; 20(6):e13391. PubMed ID: 34053152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases.
    Niehues S; Bussmann J; Steffes G; Erdmann I; Köhrer C; Sun L; Wagner M; Schäfer K; Wang G; Koerdt SN; Stum M; Jaiswal S; RajBhandary UL; Thomas U; Aberle H; Burgess RW; Yang XL; Dieterich D; Storkebaum E
    Nat Commun; 2015 Jul; 6():7520. PubMed ID: 26138142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel mutation of the glycyl-tRNA synthetase (GARS) gene associated with Charcot-Marie-Tooth type 2D in a Chinese family.
    Sun A; Liu X; Zheng M; Sun Q; Huang Y; Fan D
    Neurol Res; 2015 Sep; 37(9):782-7. PubMed ID: 26000875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene.
    James PA; Cader MZ; Muntoni F; Childs AM; Crow YJ; Talbot K
    Neurology; 2006 Nov; 67(9):1710-2. PubMed ID: 17101916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation screening of the N-myc downstream-regulated gene 1 (NDRG1) in patients with Charcot-Marie-Tooth Disease.
    Hunter M; Bernard R; Freitas E; Boyer A; Morar B; Martins IJ; Tournev I; Jordanova A; Guergelcheva V; Ishpekova B; Kremensky I; Nicholson G; Schlotter B; Lochmüller H; Voit T; Colomer J; Thomas PK; Levy N; Kalaydjieva L
    Hum Mutat; 2003 Aug; 22(2):129-35. PubMed ID: 12872253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.